NCT00365534

Brief Summary

The aim of this study is to compare the mechanism of loop formation and acceptance of CAC and regular colonoscopy by MEI.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 16, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 17, 2006

Completed
Last Updated

March 26, 2010

Status Verified

March 1, 2010

First QC Date

August 16, 2006

Last Update Submit

March 25, 2010

Conditions

Colonoscopy

Keywords

First colonoscopy examination

Outcome Measures

Primary Outcomes (1)

  • The MEI score difference between regular colonoscopy and CAC.

Interventions

MEIPROCEDURE

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patient undergo first colonoscopy examination
  • Signed informed consent

You may not qualify if:

  • Patient had received colonoscopy examination before.
  • Patient had prior colorectal surgery done(apart from appendectomy)
  • Known to have colonic stricture or obstructing tumour from the result of other investigations such as CT scan or barium enema.
  • Presence of acute surgical conditions such as severe colitis, megacolon, ischaemic colitis and active gastrointestinal bleeding.
  • Patient could not provide consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Endoscopy Centre,Alice Ho Miu Ling Nethersole Hospital & Tai Po Hospital

Hong Kong, China

Location

Study Officials

  • Yuk Tong Lee, MD

    Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 16, 2006

First Posted

August 17, 2006

Study Start

January 1, 2006

Last Updated

March 26, 2010

Record last verified: 2010-03

Locations

CN(1)